Cathie Wood makes adjustments to her portfolio in August

0


Summary

  • The guru has increased five existing holdings.
  • Wood took on new positions in two SAVS.
  • It also reduced its stake in CRISPR Therapeutics.

Catherine Wood (Trades, Wallet) last week unveiled its company, ARK Investment

PZN
Management, made a number of changes to its portfolio in August.

Wood, who is the founder, chief investment officer and CEO of the New York-based company, has made a name for herself investing in “disruptive innovation” stocks. By implementing an iterative process that combines top-down and bottom-up research, ARK Investment seeks to invest in companies that can benefit from cross-industry innovations such as artificial intelligence, robotics, energy storage, sequencing of the DNA and blockchain technology.

According to GuruFocus Real-time selections, a Premium feature, the guru increased its holdings by five shares, took new positions in two ad hoc acquisition companies and reduced its CRISPR Therapeutics AG (CRSP, Financial) by 1.69% on August 31.

Therapeutic destiny

By increasing the stake by 44.2%, the investor bought 3.3 million shares of Fate Therapeutics Inc. (SPELL, Financial). The transaction had an impact of 0.45% on the equity portfolio. The stock was trading at an average price of $ 73.25 per share on trade day.

Wood now owns 10.8 million shares in total, representing 1.46% of the share portfolio. According to GuruFocus, it has lost around 7.47% on the investment so far.

La Jolla, Calif., Based biopharmaceutical company that develops cellular immunotherapies to treat cancer patients has a market cap of $ 6.29 billion; its shares were trading around $ 66.06 on Friday with a price-to-book ratio of 8.29 and a price-to-sell ratio of 124.63.

The GF value line

VALUE
suggests that the stock is a possible value trap currently based on historical ratios, past performance and future earnings projections.

Among the gurus invested in Fate Therapeutics, Wood holds the largest stake with 11.34% of the shares outstanding. Steve mandel (Trades, Wallet), Pioneer Investments, Robert bruce (Trades, Wallet), Jim simons (Trades, Wallet) ‘Renaissance Technologies and Louis moore bacon (Trades, Wallet) also have the action.

Quantum-Si

With a 0.14% impact on the equity portfolio, Wood increased its Quantum-Si Inc. (QSI, Financial) holding 188.1%, buying 7.6 million shares. The shares traded at an average price of $ 9.72 each on trade day.

She now owns 11.6 million shares in total, or 0.21% of the share portfolio. According to GuruFocus, Wood has lost around 8.18% on the investment so far.

The Guilford, Connecticut-based biotech company, which focuses on developing a protein sequencing platform, has a market cap of $ 1.19 billion; its shares were trading around $ 8.70 on Monday with a price-to-book ratio of 2.36.

Since entering the market via the SPAC merger on June 11, the stock has gained nearly 3%.

With an 8.55% stake, Wood is Quantum-Si’s largest guru shareholder. Larry robbins (Trades, Wallet) also has a position in the stock.

Vuzix

Impacting the stock portfolio by 0.07%, the guru increased his Vuzix Corp

VUZI
. (VUZI, Financial) 69.99% stake, or 3.02 million shares. On trade day, the stock was trading at an average price per share of $ 13.23.

Wood now owns 7.35 million shares in total, representing 0.18% of the share portfolio. GuruFocus data shows it has lost around 29.73% on the investment so far.

The Rochester, New York-based tech company, which develops and manufactures smart glasses and other augmented reality technologies, has a market cap of $ 742.66 million; its shares were trading at around $ 11.73 on Monday with a price-to-book ratio of 4.75 and a price-to-sell ratio of 40.84.

According to the GF Value Line, the stock is currently significantly overvalued.

Wood owns the largest stake with 11.56% of the outstanding shares. Other major gurus shareholders include the company Simons, Lee ainslie (Trades, Wallet) and Baillie Gifford (Trades, Wallet).

908 devices

The investor boosted the 908 Devices Inc. (MASS, Financial) 12.85% position, buying 315,404 shares. The operation had an impact of 0.02% on the equity portfolio. On trade day, the stock was trading at an average price of $ 36 per share.

She now owns 2.77 million shares in total, giving her 0.19% space in the stock portfolio. According to GuruFocus, Wood has lost around 26.72% on the investment so far.

The Boston-based company, which manufactures medical devices for chemical and biomolecular analysis, has a market cap of $ 1 billion; its shares were trading at around $ 36.81 on Monday with a price-to-book ratio of 7.12 and a price-to-sell ratio of 7.41.

Since its IPO on December 18, 2020, the stock has fallen almost 25%.

Among the gurus invested in 908 devices, Wood holds the largest stake with 10.02% of the shares outstanding. Frank sands (Trades, Wallet), PRIMECAP management (Trades, Wallet), Paul Tudor Jones (Trades, Wallet) and Baillie Gifford (Trades, Wallet) also have the action.

Special Dynamics

With a 0.01% impact on the equity portfolio, Wood increased the stake in Dynamics Special Purpose Corp. (DYNS, Financial) by 13.96%, or 291,191 shares. The shares traded at an average price of $ 9.92 each on trade day.

She now owns 2.37 million shares in total, giving the holding 0.04% space in the share portfolio. The investor gained around 0.27% on the investment over its short lifespan according to GuruFocus.

The Redwood City, Calif., Headquartered blank check company, which is focused on finding a life science company to combine with, has a market cap of $ 293.18 million; its shares were trading at around $ 9.95 on Monday with a price-to-book ratio of 1.31.

Since its IPO in May, the title has lost 0.3%.

Wood holds the largest stake among the gurus with 8.07% of its shares outstanding. Jones is also invested in PSPC.

Acquisition of the booming eagle

The guru has invested in 20.57 million shares of Soaring Eagle Acquisition Corp. (SRNGU, Financial), dedicating 0.40% of the equity portfolio to participation. The stock was trading at an average price per share of $ 10.42 on trade day.

New York-based SPAC, which in May announced its merger with Ginkgo Bioworks Holdings Inc., has a market capitalization of $ 1.7 billion; its shares were trading at around $ 9.78 on Monday with a price-to-sell ratio of 1.32.

Since its public debut in February, the stock has fallen 8.38%.

Chase coleman (Trades, Wallet) and David Einhorn (Trades, Wallet) also hold positions within PSPC.

Acquisition of Khosla Ventures

Wood acquired 4.28 million shares of Khosla Ventures Acquisition Co. II (KVSB, Financial), allocating 0.08% of the equity portfolio to the holding company. On trade day, the stock was trading at an average price of $ 9.93 per share.

PSPC, headquartered in Menlo Park, Calif., Which announced in July its combination with Nextdoor Inc., has a market capitalization of $ 554.05 million; its shares were trading at around $ 10.50 on Monday.

Since its IPO in March, the title has risen 5%.

While Wood owns the largest stake in Khosla Ventures with an 8.11% stake, Daniel loeb (Trades, Wallet) also occupies an important place.

CRISPR Therapeutics

Impacting the equity portfolio by -0.03%, Wood sold 131,769 shares of CRISPR Therapeutics (CRSP, Financial). The shares traded at an average price of $ 124.95 each on trade day.

The investor now owns 7.6 million shares in total, which represents 1.78% of the share portfolio. GuruFocus data shows that it gained around 75.06% on the investment, which was established in the second quarter of 2017.

The Swiss biotech company, which develops gene-based drugs for serious diseases using its proprietary platform, has a market capitalization of $ 9.06 billion; its shares were trading at around $ 119.10 on Monday with a price-to-earnings ratio of 23.36, a price-to-pound ratio of 3.47 and a price-to-sell ratio of 10.6.

Based on the GF value line, the stock currently appears to be a possible value trap, so investors should carefully consider the company before taking a position.

With a 10.03% stake, Wood is CRISPR’s largest guru shareholder. John hussman (Trades, Wallet), Murray Stahl (Trades, Wallet), Pioneer Investments and Mario gabelli (Trades, Wallet) also have the action.

Portfolio composition and performance

More than 30% of the guru’s $ 50.33 billion equity portfolio, which consisted of 284 stocks at the end of the second quarter, is invested in the healthcare sector, followed by slightly lower exposures to spaces of communication technologies and services.

As of June 30, Wood’s top five holdings were Tesla Inc.

TSLA
(TSLA, Financial), Teladoc Health Inc

TDOC
. (TDOC, Financial), Roku Inc. (ROKU, Financial), Square inc.

SQ
(SQ, Financial) and Shopify Inc.

STORE
(STORE, Financial)

The flagship ARK Innovation Exchange-Traded Fund (ARKK, Financial) returned 152.52% in 2020, decimating the 18.4% return of the S&P 500.

Not a GuruFocus Premium member? Sign up for a 7 day free trial here.

Disclosures

I / we have no position in any of the mentioned stocks and do not intend to initiate any position within the next 72 hours.


Share.

About Author

Leave A Reply